SAN ANTONIO, Oct. 15, 2015 /PRNewswire/ -- ASTRO Booth # 828 – Varian Medical Systems (NYSE: VAR) is introducing an upgradeable single-room proton therapy system which enables fully-rotational pencil-beam scanning treatments from around $25 million. The entry-level ProBeam® Compact system, which will be highlighted next week at the 2015 annual meeting of the American Society for Radiation Oncology (ASTRO) here, offers a cost-effective way to acquire best-in-class proton therapy treatment technology, imaging, motion management and software from the world leader in advanced radiotherapy systems.
"This is the most complete single-room proton system on the market which avoids many of the compromises made by other single-room systems," says Jan Timmer, senior manager of product marketing for Varian's Particle Therapy division. "Unlike other similarly-priced systems, the entry-level ProBeam Compact can deliver the beam and generate images from 360° around the patient, providing a greater range of treatment options. It also offers unrivalled patient throughput as well as a full package of integrated image guidance and motion management tools, and its capabilities can grow over time with the clinic."
"This new platform has been designed to minimize the cost and space requirements for deploying a proton therapy system, making the adoption of proton treatments by existing cancer centers more feasible and affordable," adds Timmer.
"We have introduced this entry-level ProBeam Compact system because we believe customers do not want to compromise when making such a significant long-term investment," said Dr. Moataz Karmalawy, general manager of Varian's Particle Therapy division. "We believe proton therapy will become the standard of care for many disease sites in the future and this system makes advanced proton therapy more affordable and accessible for today's cancer patients."
Fully-Featured ProBeam Compact
A fully-featured ProBeam Compact installation includes a space-efficient cyclotron, Varian's unique Dynamic Peak™ scanning technology for intensity-modulated proton therapy (IMPT), a fully rotational gantry, robotic patient positioning tools, and a comprehensive suite of motion management tools. It incorporates cone beam CT imaging for positioning the patient based on high quality anatomical images with excellent soft tissue resolution, as well as the option of planning and managing treatments using Varian's world class Eclipse™ and ARIA® software systems.
The ProBeam Compact system is operated using the same interface Varian developed for its industry leading TrueBeam® platform, offering users a streamlined treatment console that consolidates controls for imaging, treatment, and motion management in one graphical, user-friendly interface. Operators who use Varian technology to plan and deliver conventional radiotherapy can easily learn to use and quickly ramp up to use the ProBeam system because they can leverage their prior experience with other Varian systems.
Varian's ProBeam technology is being used to treat patients at the Scripps Proton Therapy Center in San Diego, the Rinecker Proton Therapy Center in Munich, and at the Paul Scherrer Institute in Switzerland. Varian also has contracts for system installations at 12 other sites around the world.
About Varian Medical Systems
Varian Medical Systems, Inc. (NYSE: VAR), of Palo Alto, California, focuses energy on saving lives by equipping the world with advanced technology for fighting cancer and for X-ray imaging. The company is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiation. The company provides comprehensive solutions for radiotherapy, radiosurgery, proton therapy and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is also a premier supplier of X-ray imaging components, including tubes, digital detectors, and image processing software and workstations for use in medical, scientific, and industrial settings, as well as for security and non-destructive testing. Varian Medical Systems employs approximately 6,900 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.
Forward Looking Statements
Except for historical information, this news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this press release regarding future business, plans, objectives, expectations and other similar matters; market acceptance of products or technology for proton therapy; timing and ability to achieve certain results; and any statements using the terms "enables," "offers," "can," "feasible," and "will," are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those anticipated. These risks and uncertainties include demand for the company's proton therapy products; the company's ability to develop and commercialize new proton therapy products; the company's ability to meet regulatory regulations or procedures; the company's ability to protect the company's intellectual property; and the other risks listed from time to time in the company's filings with the Securities and Exchange Commission, which by this reference are incorporated herein. These forward-looking statements represent the Company's judgment as of the date of this press release. The Company assumes no obligation to update or revise these forward-looking statements because of new information, future events, or otherwise.
Varian Medical Systems
+44 7786 526068
SOURCE Varian Medical Systems